Global Influenza Diagnostics Market Size study, by Test type (Traditional Diagnostic Tests, Molecular Diagnostic Tests), by End user (Hospitals, Clinical Laboratories, Other End-User) and Regional Forecasts 2020-2026
Global Influenza Diagnostics Market is valued approximately at USD 646.5 million in 2019 and is anticipated to grow with a growth rate of more than 7.8% over the forecast period 2020-2026. Influenza is an infectious respiratory infection caused via flu viruses. Each year seasonal influenza affects millions of people leading thousands of hospitalizations and flu-related deaths. As per the World Health Organization report 2019, every year there are an estimated 1 billion cases Influenza, about 3-5 million severe cases of influenza, and 290 000-650 000 influenza-associated respiratory deaths worldwide. Influenza outbreaks have encouraged healthcare authorities across the world to upsurge the capacity of influenza diagnosis, which is further contributing towards the adoption of influenza diagnostics. Global influenza diagnostic market growth is mainly driven by aspects such as the growing incidence of influenza, growing in research funding for influenza diagnostics, and the growing demand for faster diagnosis. Furthermore, the increasing approvals of influenza diagnostic products by governing authorities is expected to create significant growth opportunity for the market over the forecast period. For instance, Abbott Laboratories received FDA clearance for ID NOW Influenza A & B 2 Assay product in 2018. Similarly, Quidel Corporation received FDA clearance for QuickVue Influenza A+B Test product. However, complex regulatory framework for the approval of new diagnostic tests impedes the growth of the market over the forecast period of 2020-2026.
The regional analysis of global Influenza Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing prevalence of influenza and advanced healthcare facilities in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as developing healthcare infrastructure, increasing prevalence of diseases would create lucrative growth prospects for the Influenza Diagnostics market across Asia-Pacific region.
Major market player included in this report are:
F. Hoffmann-La Roche AG
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Hologic Inc.
Becton, Dickinson, and Company
DiaSorin S.p.A
Luminex Corporation
Meridian Bioscience Inc.
GenMark Diagnostics
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Test type:
Traditional Diagnostic Tests
Molecular Diagnostic Tests
By End user:
Hospitals
Clinical Laboratories
Other End-User
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Influenza Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global Influenza Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing prevalence of influenza and advanced healthcare facilities in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as developing healthcare infrastructure, increasing prevalence of diseases would create lucrative growth prospects for the Influenza Diagnostics market across Asia-Pacific region.
Major market player included in this report are:
F. Hoffmann-La Roche AG
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Hologic Inc.
Becton, Dickinson, and Company
DiaSorin S.p.A
Luminex Corporation
Meridian Bioscience Inc.
GenMark Diagnostics
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Test type:
Traditional Diagnostic Tests
Molecular Diagnostic Tests
By End user:
Hospitals
Clinical Laboratories
Other End-User
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Influenza Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Influenza Diagnostics Market, by Region, 2018-2026 (USD Million)
1.2.2. Influenza Diagnostics Market, by Test type, 2018-2026 (USD Million)
1.2.3. Influenza Diagnostics Market, by End user, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INFLUENZA DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INFLUENZA DIAGNOSTICS MARKET DYNAMICS
3.1. Influenza Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL INFLUENZA DIAGNOSTICS MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE
5.1. Market Snapshot
5.2. Global Influenza Diagnostics Market by Test type, Performance - Potential Analysis
5.3. Global Influenza Diagnostics Market Estimates & Forecasts by Test type 2016-2026 (USD Million)
5.4. Influenza Diagnostics Market, Sub Segment Analysis
5.4.1. Traditional Diagnostic Tests
5.4.2. Molecular Diagnostic Tests
CHAPTER 6. GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY END USER
6.1. Market Snapshot
6.2. Global Influenza Diagnostics Market by End user, Performance - Potential Analysis
6.3. Global Influenza Diagnostics Market Estimates & Forecasts by End user 2016-2026 (USD Million)
6.4. Influenza Diagnostics Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Clinical Laboratories
6.4.3. Other End-User
CHAPTER 7. GLOBAL INFLUENZA DIAGNOSTICS MARKET, REGIONAL ANALYSIS
7.1. Influenza Diagnostics Market, Regional Market Snapshot
7.2. North America Influenza Diagnostics Market
7.2.1. U.S. Influenza Diagnostics Market
7.2.1.1. Test type breakdown estimates & forecasts, 2016-2026
7.2.1.2. End user breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Influenza Diagnostics Market
7.3. Europe Influenza Diagnostics Market Snapshot
7.3.1. U.K. Influenza Diagnostics Market
7.3.2. Germany Influenza Diagnostics Market
7.3.3. Rest of Europe Influenza Diagnostics Market
7.4. Asia-Pacific Influenza Diagnostics Market Snapshot
7.4.1. China Influenza Diagnostics Market
7.4.2. India Influenza Diagnostics Market
7.4.3. Japan Influenza Diagnostics Market
7.4.4. Rest of Asia Pacific Influenza Diagnostics Market
7.5. Latin America Influenza Diagnostics Market Snapshot
7.5.1. Brazil Influenza Diagnostics Market
7.5.2. Mexico Influenza Diagnostics Market
7.6. Rest of The World Influenza Diagnostics Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. F. Hoffmann-La Roche AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Quidel Corporation
8.2.3. Thermo Fisher Scientific
8.2.4. Abbott Laboratories
8.2.5. Hologic Inc.
8.2.6. Becton, Dickinson, and Company
8.2.7. DiaSorin S.p.A
8.2.8. Luminex Corporation
8.2.9. Meridian Bioscience Inc.
8.2.10. GenMark Diagnostics
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Influenza Diagnostics Market, by Region, 2018-2026 (USD Million)
1.2.2. Influenza Diagnostics Market, by Test type, 2018-2026 (USD Million)
1.2.3. Influenza Diagnostics Market, by End user, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INFLUENZA DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INFLUENZA DIAGNOSTICS MARKET DYNAMICS
3.1. Influenza Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL INFLUENZA DIAGNOSTICS MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE
5.1. Market Snapshot
5.2. Global Influenza Diagnostics Market by Test type, Performance - Potential Analysis
5.3. Global Influenza Diagnostics Market Estimates & Forecasts by Test type 2016-2026 (USD Million)
5.4. Influenza Diagnostics Market, Sub Segment Analysis
5.4.1. Traditional Diagnostic Tests
5.4.2. Molecular Diagnostic Tests
CHAPTER 6. GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY END USER
6.1. Market Snapshot
6.2. Global Influenza Diagnostics Market by End user, Performance - Potential Analysis
6.3. Global Influenza Diagnostics Market Estimates & Forecasts by End user 2016-2026 (USD Million)
6.4. Influenza Diagnostics Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Clinical Laboratories
6.4.3. Other End-User
CHAPTER 7. GLOBAL INFLUENZA DIAGNOSTICS MARKET, REGIONAL ANALYSIS
7.1. Influenza Diagnostics Market, Regional Market Snapshot
7.2. North America Influenza Diagnostics Market
7.2.1. U.S. Influenza Diagnostics Market
7.2.1.1. Test type breakdown estimates & forecasts, 2016-2026
7.2.1.2. End user breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Influenza Diagnostics Market
7.3. Europe Influenza Diagnostics Market Snapshot
7.3.1. U.K. Influenza Diagnostics Market
7.3.2. Germany Influenza Diagnostics Market
7.3.3. Rest of Europe Influenza Diagnostics Market
7.4. Asia-Pacific Influenza Diagnostics Market Snapshot
7.4.1. China Influenza Diagnostics Market
7.4.2. India Influenza Diagnostics Market
7.4.3. Japan Influenza Diagnostics Market
7.4.4. Rest of Asia Pacific Influenza Diagnostics Market
7.5. Latin America Influenza Diagnostics Market Snapshot
7.5.1. Brazil Influenza Diagnostics Market
7.5.2. Mexico Influenza Diagnostics Market
7.6. Rest of The World Influenza Diagnostics Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. F. Hoffmann-La Roche AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Quidel Corporation
8.2.3. Thermo Fisher Scientific
8.2.4. Abbott Laboratories
8.2.5. Hologic Inc.
8.2.6. Becton, Dickinson, and Company
8.2.7. DiaSorin S.p.A
8.2.8. Luminex Corporation
8.2.9. Meridian Bioscience Inc.
8.2.10. GenMark Diagnostics
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. List of secondary sources, used in the study of global Influenza Diagnostics market
TABLE 2. List of primary sources, used in the study of global Influenza Diagnostics market
TABLE 3. Global Influenza Diagnostics market, report scope
TABLE 4. Years considered for the study
TABLE 5. Exchange rates considered
TABLE 6. Global Influenza Diagnostics market estimates & forecasts by region 2016-2026 (USD Million)
TABLE 7. Global Influenza Diagnostics market estimates & forecasts by Test type 2016-2026 (USD Million)
TABLE 8. Global Influenza Diagnostics market estimates & forecasts by End user 2016-2026 (USD Million)
TABLE 9. Global Influenza Diagnostics market estimates & forecasts by Product type 2016-2026 (USD Million)
TABLE 10. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 11. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD Million)
TABLE 12. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 13. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD Million)
TABLE 14. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 15. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD Million)
TABLE 16. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 17. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD Million)
TABLE 18. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 19. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD MILLION)
TABLE 20. U.S. Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD MILLION)
TABLE 21. U.S. Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 22. U.S. Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 23. CANADA Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD MILLION)
TABLE 24. CANADA Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 25. Canada Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 26. UK Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD MILLION)
TABLE 27. UK Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 28. UK Influenza Diagnostics Market Estimates & Forecasts by Segment 2016-2026 (USD MILLION)
TABLE 29. Germany Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 30. Germany Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 31. Germany Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 32. Roe Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 33. Roe Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 34. Roe Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 35. China Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 36. China Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 37. China Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 38. India Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 39. India Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 40. India Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 41. Japan Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 42. Japan Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 43. Japan Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 44. ROAPAC Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 45. ROAPAC Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 46. ROAPAC Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 47. Brazil Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 48. Brazil Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 49. Brazil Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 50. Mexico Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 51. Mexico Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 52. Mexico Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 53. ROLA Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 54. ROLA Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 55. ROLA Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 56. ROW Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 57. ROW Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 58. ROW Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 1. List of secondary sources, used in the study of global Influenza Diagnostics market
TABLE 2. List of primary sources, used in the study of global Influenza Diagnostics market
TABLE 3. Global Influenza Diagnostics market, report scope
TABLE 4. Years considered for the study
TABLE 5. Exchange rates considered
TABLE 6. Global Influenza Diagnostics market estimates & forecasts by region 2016-2026 (USD Million)
TABLE 7. Global Influenza Diagnostics market estimates & forecasts by Test type 2016-2026 (USD Million)
TABLE 8. Global Influenza Diagnostics market estimates & forecasts by End user 2016-2026 (USD Million)
TABLE 9. Global Influenza Diagnostics market estimates & forecasts by Product type 2016-2026 (USD Million)
TABLE 10. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 11. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD Million)
TABLE 12. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 13. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD Million)
TABLE 14. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 15. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD Million)
TABLE 16. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 17. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD Million)
TABLE 18. Global Influenza Diagnostics market by segment, estimates & forecasts, 2016-2026 (USD Million)
TABLE 19. Global Influenza Diagnostics market by region, estimates & forecasts, 2016-2026 (USD MILLION)
TABLE 20. U.S. Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD MILLION)
TABLE 21. U.S. Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 22. U.S. Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 23. CANADA Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD MILLION)
TABLE 24. CANADA Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 25. Canada Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 26. UK Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD MILLION)
TABLE 27. UK Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD MILLION)
TABLE 28. UK Influenza Diagnostics Market Estimates & Forecasts by Segment 2016-2026 (USD MILLION)
TABLE 29. Germany Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 30. Germany Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 31. Germany Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 32. Roe Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 33. Roe Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 34. Roe Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 35. China Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 36. China Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 37. China Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 38. India Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 39. India Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 40. India Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 41. Japan Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 42. Japan Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 43. Japan Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 44. ROAPAC Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 45. ROAPAC Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 46. ROAPAC Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 47. Brazil Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 48. Brazil Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 49. Brazil Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 50. Mexico Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 51. Mexico Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 52. Mexico Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 53. ROLA Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 54. ROLA Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 55. ROLA Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 56. ROW Influenza Diagnostics market estimates & forecasts, 2016-2026 (USD Million)
TABLE 57. ROW Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
TABLE 58. ROW Influenza Diagnostics market estimates & forecasts by segment 2016-2026 (USD Million)
LIST OF FIGURES
FIG 1. Global Influenza Diagnostics market, research methodology
FIG 2. Global Influenza Diagnostics market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Influenza Diagnostics market, key trends 2019
FIG 5. Global Influenza Diagnostics market, growth prospects 2020-2026
FIG 6. Global Influenza Diagnostics market, porters 5 force model
FIG 7. Global Influenza Diagnostics market, pest analysis
FIG 8. Global Influenza Diagnostics market, value chain analysis
FIG 9. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 10. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 11. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 12. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 13. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 14. Global Influenza Diagnostics market, regional snapshot 2016 & 2026
FIG 15. North America Influenza Diagnostics market 2016 & 2026 (USD Million)
FIG 16. Europe Influenza Diagnostics market 2016 & 2026 (USD Million)
FIG 17. Asia pacific Influenza Diagnostics market 2016 & 2026 (USD Million)
FIG 18. Latin America Influenza Diagnostics market 2016 & 2026 (USD Million)
FIG 19. Global Influenza Diagnostics market, company market share analysis (2019)
COMPANIES MENTIONED
F. Hoffmann-La Roche AG
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Hologic Inc.
Becton, Dickinson, and Company
DiaSorin S.p.A
Luminex Corporation
Meridian Bioscience Inc.
GenMark Diagnostics
FIG 1. Global Influenza Diagnostics market, research methodology
FIG 2. Global Influenza Diagnostics market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Influenza Diagnostics market, key trends 2019
FIG 5. Global Influenza Diagnostics market, growth prospects 2020-2026
FIG 6. Global Influenza Diagnostics market, porters 5 force model
FIG 7. Global Influenza Diagnostics market, pest analysis
FIG 8. Global Influenza Diagnostics market, value chain analysis
FIG 9. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 10. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 11. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 12. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 13. Global Influenza Diagnostics market by segment, 2016 & 2026 (USD Million)
FIG 14. Global Influenza Diagnostics market, regional snapshot 2016 & 2026
FIG 15. North America Influenza Diagnostics market 2016 & 2026 (USD Million)
FIG 16. Europe Influenza Diagnostics market 2016 & 2026 (USD Million)
FIG 17. Asia pacific Influenza Diagnostics market 2016 & 2026 (USD Million)
FIG 18. Latin America Influenza Diagnostics market 2016 & 2026 (USD Million)
FIG 19. Global Influenza Diagnostics market, company market share analysis (2019)
COMPANIES MENTIONED
F. Hoffmann-La Roche AG
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Hologic Inc.
Becton, Dickinson, and Company
DiaSorin S.p.A
Luminex Corporation
Meridian Bioscience Inc.
GenMark Diagnostics
